Postoperative Nausea and Vomiting
Conditions
Interventions
This is a randomized, controlled, parallel-group, double-blind clinical trial involving 40 individuals undergoing abdominoplasty surgery. Participants will be randomly allocated into two groups of 20
Sponsors
Universidade Regional Integrada do Alto do Uruguai e das Missões
Universidade Regional Integrada do Alto do Uruguai e das Missões
Eligibility
Inclusion criteria
Inclusion criteria: Perform abdominoplasty surgery at Hospital Unimed de Erechim with the team of plastic surgeons led by Dr. Cassiano Furtado Beller. Both sexes
Exclusion criteria
Exclusion criteria: Have serious psychiatric disorders. Being allergic to opioids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: A lower use of rescue opioids is expected in the intervention group during the postoperative period, based on patient needs assessed using the numerical pain scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 1: A lower incidence of undesirable adverse effects, such as nausea and vomiting, is expected in the intervention group | — |
Countries
Brazil
Contacts
Public ContactVerônica Corradi
Universidade Regional Integrada do Alto do Uruguai e das Missões
Outcome results
None listed